Abstract
AbstractInflammatory bowel disease (IBD) is a class of chronic disorders whose etiogenesis is still unknown. Despite the high number of IBD-related omics studies, the RNA-sequencing data produced results that are hard to compare because of the experimental variability and different data analysis approaches. We here introduce the IBD Transcriptome and Metatranscriptome Meta-Analysis (TaMMA) framework, a comprehensive survey of publicly available IBD RNA-sequencing datasets. IBD TaMMA is an open-source platform where scientists can explore simultaneously the freely available IBD-associated transcriptomics and microbial profiles thanks to its interactive interface, resulting in a useful tool to the IBD community.
Funder
Innovative Medicines Initiative
Fondazione Cariplo
Fondazione Amici ONLUS ITALIA, research prize to FU
Publisher
Springer Science and Business Media LLC
Reference32 articles.
1. Aldars-García, L., Marin, A. C., Chaparro, M. & Gisbert, J. P. The interplay between immune system and microbiota in inflammatory bowel disease: a narrative review. Int. J. Mol. Sci. 22, 3076 (2021).
2. Seyed Tabib, N. S. et al. Big data in IBD: big progress for clinical practice. Gut 69, 1520–1532 (2020).
3. Li, X. et al. Meta-analysis of expression profiling data indicates need for combinatorial biomarkers in pediatric ulcerative colitis. J. Immunol. Res. 2020, 8279619 (2020).
4. Naz, S. et al. Transcriptome meta-analysis identifies immune signature comprising of RNA binding proteins in ulcerative colitis patients. Cell. Immunol. 334, 42–48 (2018).
5. Vennou, K. E., Piovani, D., Kontou, P. I., Bonovas, S. & Bagos, P. G. Multiple outcome meta-analysis of gene-expression data in inflammatory bowel disease. Genomics 112, 1761–1767 (2020).
Cited by
36 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献